Recent News for ORGO - Organogenesis Holdings Inc.

Date Title
Mar 4 Tech Stocks Take A Beating: This Is How To Make Tricky Trading Decisions In Tough Markets
Feb 16 Organogenesis Appoints David C. Francisco as Chief Financial Officer
Feb 11 The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
Feb 9 Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February and March
Feb 9 The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
Feb 8 Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 16, 2021
Feb 4 Organogenesis Holdings' (ORGO) Shares March Higher, Can It Continue?
Jan 21 The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Jan 20 Earnings Estimates Rising for ORGANOGENESIS (ORGO): Will It Gain?
Jan 15 The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Jan 14 Corbus Pharmaceuticals (CRBP) Catches Eye: Stock Jumps 7.3%
Jan 14 The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
Jan 14 Enrollment underway in Organogenesis' late-stage study with amniotic allograft for knee OA
Jan 14 Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu® for Knee Osteoarthritis
Jan 13 Organogenesis +23% AH, expects revenue to rise 40-42% Y/Y
Jan 13 Organogenesis Holdings Inc. Reports Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020
Jan 11 Organogenesis' ReNu wins FDA's RMAT status
Jan 11 Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee
Jan 7 How Much Of Organogenesis Holdings Inc. (NASDAQ:ORGO) Do Insiders Own?
Jan 5 Organogenesis Holdings Inc. to Participate in the ICR Conference 2021
Jan 5 The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
Dec 30 The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data
Dec 29 The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
Dec 26 Organogenesis Holdings: Accumulate On Dips
Dec 23 The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
Back to the Main ORGO Page...